Interleukin-4 is a pleotropic cytokine with effects on B-cell malignancies

This publication has 20 references indexed in Scilit:

• Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors
  Blood, 1992
• Long-Term Human B Cell Lines Dependent on Interleukin-4 and antibody to CD40
  Science, 1991
• CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells.
  The Journal of Experimental Medicine, 1990
• Dual effects of interleukin 4 on antigen‐activated human B cells: induction of proliferation and inhibition of interleukin 2‐dependent differentiation
  European Journal of Immunology, 1990
• Interleukin-4 induces a substance in bone marrow stromal cells that reversibly inhibits factor-dependent and factor-independent cell proliferation
  Blood, 1989
• Two species of human Fcε receptor II ( ): Tissue-specific and IL-4-specific regulation of gene expression
  Cell, 1988
• Interleukin 4 inhibits the proliferation but not the differentiation of activated human B cells in response to interleukin 2.
  The Journal of Experimental Medicine, 1988
• Interleukin 4 counteracts the interleukin 2-induced proliferation of monoclonal B cells.
  The Journal of Experimental Medicine, 1988
• Nomenclature of lymphokines which regulate B-lymphocytes
  Molecular Immunology, 1984
• Identification of a T cell-derived b cell growth factor distinct from interleukin 2.
  The Journal of Experimental Medicine, 1982